Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Hidekazu Shirota, Dennis M. Klinman

Research output: Contribution to journalReview articlepeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)787-789
Number of pages3
JournalImmunotherapy
Volume5
Issue number8
DOIs
Publication statusPublished - 2013 Aug

Keywords

  • CpG oligonucleotide
  • Toll-like receptor 9
  • cancer immunotherapy
  • myeloid-derived suppressor cell

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this